OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


 

Teeling Smith, G.

Briefing
March 1989

The objective of medical care is to make people as healthy as possible. Over the past 40 years, since the National Health Service was established in Britain, medical progress - including particularly pharmacological advances - has greatly extended the scope for the health services to achieve this objective. However, this success has also led to steadily rising expenditure on the Health Service. As a result, there has been a very proper concern to ensure that this expenditure is as effective as possible. The latest Health Service Review (HMSO.

Monograph
February 1989

Despite much of the current discussion, Britain's National Health Service has been an outstanding success during its 40 years of existence. Its present problems stem primarily from the way in which the scope for medical care within the service has been extended so dramatically since 1948.

Teeling Smith, G.

Briefing
September 1988

The Office of Health Economics first drew attention to the fact that every country in Europe had some form of prepaid national health care scheme in a publication in 1963.

Shao, Y.

Series on Health
September 1988

In this report our visiting scholar. Yinong Shao, has produced a fascinating picture of the health services in China in 1988. It is particularly remarkable because even a few years ago the wealth of statistics which it contains could not have been published. First and foremost Shao's Report is an indication of the new enlightened approach by the Chinese in allowing international discussion of their internal affairs.

Wells, N.

Series on Health
December 1986

In purely quantitative terms, acquired immune deficiency syndrome (AIDS) might not appear to have warranted the remarkable amount of attention it has attracted since 1982. By the end of October 1986 a total of just 548 cases of AIDS in the UK had been reported to the Communicable Disease Surveillance Centre. This sum pales in comparison with the contemporary incidence of respiratory tuberculosis - equally a scourge of mankind that is now, and for some time has been, 'under control'.

Teeling Smith, G.

Series on Health
June 1986

This paper from the Office of Health Economics contains some of the newer ideas which have been floated in order to tackle the economic problems urgently facing the National Health Service in 1986. It is postulated on the belief that the service not only needs additional public funds, but also needs to look at new economic principles in relation to its organisation. Above all there needs to be a better informed debate about the economics of health.

Teeling Smith, G. ed.

Monograph
January 1986

This booklet is based on a meeting organised by the Office of Health Economics and chaired by Sir John Butterfield at the Ciba Foundation on 30th October 1985. The meeting was a follow-up to a similar more general OHE discussion held at Cumberland Lodge in June 1984, whose proceedings were published under the title 'A New NHS Act for 1996?'

Laing, W.

Series on Health
July 1985

This survey covers all major areas of health care in Britain and describes the activity of the private and voluntary sectors in each. The organisation of chapters aims to follow coherent market boundaries. In many cases, these coincide roughly with NHS administrative divisions. The congruence breaks down, however, in the case of long term nursing and residential care of elderly people.

Chew, R., Teeling Smith, G. and Wells, N.

Monograph
May 1985

Great Britain at the suggestion of and in close collaboration with Medizinisch Pharmazeutische Studiengesellschaft (MPS) in the Federal Republic of Germany, OHE is funded entirely by the Association of the British Pharmaceutical Industry and MPS by seven research-based companies in Germany. The Report describes the modern research-based pharmaceutical industry, with particular reference to its structure and activities in seven countries - the Federal Republic of Germany, France, Italy, Japan, Switzerland, the United Kingdom and the United States.

Pages